Saltar al contenido
Merck

GPR174 knockdown enhances blood flow recovery in hindlimb ischemia mice model by upregulating AREG expression.

Nature communications (2022-12-07)
Jin Liu, Lihong Pan, Wenxuan Hong, Siqin Chen, Peiyuan Bai, Wei Luo, Xiaolei Sun, Furong He, Xinlin Jia, Jialiang Cai, Yingjie Chen, Kai Hu, Zhenju Song, Junbo Ge, Aijun Sun
RESUMEN

Regulatory T cells (Tregs) are critically involved in neovascularization, an important compensatory mechanism in peripheral artery disease. The contribution of G protein coupled receptor 174 (GPR174), which is a regulator of Treg function and development, in neovascularization remains elusive. Here, we show that genetic deletion of GPR174 in Tregs potentiated blood flow recovery in mice after hindlimb ischemia. GPR174 deficiency upregulates amphiregulin (AREG) expression in Tregs, thereby enhancing endothelial cell functions and reducing pro-inflammatory macrophage polarization and endothelial cell apoptosis. Mechanically, GPR174 regulates AREG expression by inhibiting the nuclear accumulation of early growth response protein 1 (EGR1) via Gαs/cAMP/PKA signal pathway activation. Collectively, these findings demonstrate that GPR174 negatively regulates angiogenesis and vascular remodeling in response to ischemic injury and that GPR174 may be a potential molecular target for therapeutic interventions of ischemic vascular diseases.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Dispasa® II, protease
Sigma-Aldrich
M-CSF from mouse, Animal-component free, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture